97123429 - VICORE ALMEE

Information

  • Trademark
  • 97123429
  • Serial Number
    97123429
  • Registration Number
    7058751
  • Filing Date
    November 12, 2021
    3 years ago
  • Registration Date
    May 23, 2023
    2 years ago
  • Transaction Date
    May 23, 2023
    2 years ago
  • Status Date
    May 23, 2023
    2 years ago
  • Published for Opposition Date
    March 07, 2023
    2 years ago
  • Location Date
    May 23, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    RILEY, KATHERINE M
  • Attorney Docket Number
    10234VP-4
    Attorney Name
    Sarah J. Schneider
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
4000
Mark Identification
VICORE ALMEE
Case File Statements
  • GS0411: Providing of on-line training and continuing education in the nature of virtual lectures in the field of medicine, health and wellness for users in the medical fields with the aid of software; Educational services, namely, providing continuing professional education courses, webinars, seminars, and workshops in the field of medicine, health and wellness for patients suffering from depression and anxiety related to Pulmonary Fibrosis and for medical personnel specialized on the treatment of depression and anxiety
  • GS0091: Downloadable computer software with medical information and content for facilitating the provision of medical advice in the field of depression and anxiety related to Pulmonary Fibrosis; downloadable computer software programs for the administration of scientific content in the nature of analysis of medical data; downloadable computer programs, in particular interactive downloadable medical software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; downloadable computer software program which is designed to assist patients in reducing and coping with the symptoms of depression and anxiety related to Pulmonary Fibrosis as well as in improving their wellbeing and social occupational functioning and to support health care professionals involved in the treatment of patients with depression and anxiety related to Pulmonary Fibrosis by facilitating the provision of medical advice; downloadable computer application software for websites, mobile telephones and mobile devices, namely, software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; Downloadable printable educational materials featuring therapeutic medical and counseling content, in the nature of information, forms, instructions, charts, studies, data and related coaching and advice in the field of depression and anxiety related to Pulmonary Fibrosis, treatment of depression and anxiety related to Pulmonary Fibrosis, and related health and wellness; Downloadable electronic publications, namely, newsletters and articles for use by medical professionals and patients in the field of depression and anxiety related to Pulmonary Fibrosis
  • GS0441: Therapeutic services, namely, medical counselling, psychological counselling, medical advice and medical information provided to patients with, and care givers treating, depression and anxiety related to Pulmonary Fibrosis; Providing medical information, namely, computer-based interactive medical support services, in the nature of providing online medical advice for assisting with treatment of patients suffering from depression and anxiety related to Pulmonary Fibrosis and their families; Medical treatment of depression and anxiety by medical personnel
  • GS0421: Providing a website featuring digital therapeutic technology that enables users to access resources for treating depression and anxiety related to Pulmonary Fibrosis; providing an online digital therapeutic platform in the nature of providing on-line non-downloadable software for providing behavioral health services, namely, coaching, counseling, advice in the field of depression and anxiety related to Pulmonary Fibrosis; conducting medical and scientific and technological research in the field of depression and anxiety related to Pulmonary Fibrosis; Scientific and technological services, namely, conducting technological research and design of digital therapeutics for computer-based interactive and online psychological intervention and counseling in the field of depression and anxiety related to Pulmonary Fibrosis; providing temporary use of non-downloadable computer programs for administration of digital therapeutic and medical content in the field of depression and anxiety related to Pulmonary Fibrosis and the treatment of depression and anxiety related to Pulmonary Fibrosis
Case File Event Statements
  • 5/23/2023 - 2 years ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 5/23/2023 - 2 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/7/2023 - 2 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/7/2023 - 2 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/15/2023 - 2 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/1/2023 - 2 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/1/2023 - 2 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/1/2023 - 2 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/1/2023 - 2 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/1/2023 - 2 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/19/2023 - 2 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/19/2023 - 2 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/19/2023 - 2 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/9/2023 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/9/2023 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/6/2023 - 2 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 11/9/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/2/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/2/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/2/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/23/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/19/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/16/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP